EP1173461A4 - 50 humansekretierte proteine - Google Patents

50 humansekretierte proteine

Info

Publication number
EP1173461A4
EP1173461A4 EP00915026A EP00915026A EP1173461A4 EP 1173461 A4 EP1173461 A4 EP 1173461A4 EP 00915026 A EP00915026 A EP 00915026A EP 00915026 A EP00915026 A EP 00915026A EP 1173461 A4 EP1173461 A4 EP 1173461A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00915026A
Other languages
English (en)
French (fr)
Other versions
EP1173461A1 (de
Inventor
Craig A Rosen
Steven M Ruben
George Komatsoulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1173461A1 publication Critical patent/EP1173461A1/de
Publication of EP1173461A4 publication Critical patent/EP1173461A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP00915026A 1999-03-26 2000-03-23 50 humansekretierte proteine Withdrawn EP1173461A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12659799P 1999-03-26 1999-03-26
US126597P 1999-03-26
US17487700P 2000-01-07 2000-01-07
US174877P 2000-01-07
PCT/US2000/007726 WO2000058336A1 (en) 1999-03-26 2000-03-23 50 human secreted proteins

Publications (2)

Publication Number Publication Date
EP1173461A1 EP1173461A1 (de) 2002-01-23
EP1173461A4 true EP1173461A4 (de) 2003-10-29

Family

ID=26824845

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00915026A Withdrawn EP1173461A4 (de) 1999-03-26 2000-03-23 50 humansekretierte proteine

Country Status (5)

Country Link
EP (1) EP1173461A4 (de)
JP (1) JP2002539816A (de)
AU (1) AU3632900A (de)
CA (1) CA2368376A1 (de)
WO (1) WO2000058336A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523207A (ja) 2000-01-25 2003-08-05 ジェネンテック・インコーポレーテッド Ｌｉｖ−１関連タンパク質、それをコードするポリヌクレオチド、及び癌の治療へのその利用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995033480A1 (en) * 1994-06-07 1995-12-14 The Government Of The United States Of America, Re Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
WO1998040483A2 (en) * 1997-03-14 1998-09-17 Human Genome Sciences, Inc. 28 human secreted proteins
WO1998045712A2 (en) * 1997-04-08 1998-10-15 Human Genome Sciences, Inc. 20 human secreted proteins
EP1213349A1 (de) * 1999-08-31 2002-06-12 Hisamitsu Pharmaceutical Co. Inc. DELETIONSDOMäNE DER MENSCHLICHEN 1Q36 HOMOZYGOTIE

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995033480A1 (en) * 1994-06-07 1995-12-14 The Government Of The United States Of America, Re Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
WO1998040483A2 (en) * 1997-03-14 1998-09-17 Human Genome Sciences, Inc. 28 human secreted proteins
WO1998045712A2 (en) * 1997-04-08 1998-10-15 Human Genome Sciences, Inc. 20 human secreted proteins
EP1213349A1 (de) * 1999-08-31 2002-06-12 Hisamitsu Pharmaceutical Co. Inc. DELETIONSDOMäNE DER MENSCHLICHEN 1Q36 HOMOZYGOTIE

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 16 October 1997 (1997-10-16), LAMERDIN JE ET AL.: "Sequence analysis of a 1 Mb region in 19q13.1", XP002237730, Database accession no. AC002997 *
DATABASE EMBL [online] 17 September 1999 (1999-09-17), XP002237731, Database accession no. AC010609 *
DATABASE EMBL [online] 23 December 1998 (1998-12-23), ADAMS M.D. ET AL: "Use of human BAC End Sequences for Sequence-Ready Map Building", XP002237729, Database accession no. AQ313550 *
DATABASE EMBL [online] 30 March 1994 (1994-03-30), XP002237728, Database accession no. X76498 *
DATABASE EMBL [online] 6 August 1999 (1999-08-06), XP002237732, Database accession no. AC009185 *
GORBULEV V ET AL: "ORGANIZATION AND CHROMOSOMAL LOCALIZATION OF THE GENE FOR THE HUMAN BOMBESIN RECEPTOR SUBTYPE EXPRESSED IN PREGNANT UTERUS", FEBS LETTERS, vol. 340, X76498, 1994, pages 260 - 264, XP002913585, ISSN: 0014-5793 *
See also references of WO0058336A1 *

Also Published As

Publication number Publication date
WO2000058336A1 (en) 2000-10-05
EP1173461A1 (de) 2002-01-23
CA2368376A1 (en) 2000-10-05
AU3632900A (en) 2000-10-16
JP2002539816A (ja) 2002-11-26

Similar Documents

Publication Publication Date Title
EP1218408A4 (de) 32 menschliche, sekretierte proteine
EP1212343A4 (de) 52 menschliche sekretierte proteine
EP1181390A4 (de) 27 menschliche, sekretierte proteine
EP1224285A4 (de) 27 menschliche sekretierte proteine
EP1212342A4 (de) 18 human-sekretierte proteine
EP1226231A4 (de) 19 humane sekretierte proteine
EP1175438A4 (de) 62 humane sekretierte proteine
EP1192176A4 (de) 49 menschliche sekretierte proteine
EP1192278A4 (de) 48 menschliche sekretierte proteine
EP1165827A4 (de) 45 humane sekretierte proteine
EP1175439A4 (de) 49 humane sekretierte proteine
EP1159284A4 (de) 33 human sekrteierte proteine
EP1189917A4 (de) 48 menschliche sekretierte proteine
EP1185543A4 (de) 50 human-sekretierte proteine
EP1173477A4 (de) 49 humane sekretierte Proteine
EP1224201A4 (de) 32 vom menschen abgesonderte proteine
EP1203005A4 (de) 25 humane sekretierte proteine
EP1206573A4 (de) 26 humane sekretionsproteine
EP1144614A4 (de) Menschliche, ausgeschiedene proteine
EP1171460A4 (de) 48 menschliche sekretierte proteine
EP1165602A4 (de) 49 menschliche, sekretierte proteine
EP1169332A4 (de) 49 human sekrtierte proteine
EP1165828A4 (de) 50 menschliche sekretierte proteine
EP1228082A4 (de) 29 humansekretierte proteine
EP1185285A4 (de) 49 humane sekretierte proteine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011005

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030912

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20040505